Azenta (AZTA)
(Delayed Data from NSDQ)
$53.67 USD
+0.85 (1.61%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $53.71 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AZTA 53.67 +0.85(1.61%)
Will AZTA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AZTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AZTA
10x Genomics (TXG) Surges 8.2%: Is This an Indication of Further Gains?
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
AZTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
Other News for AZTA
What's Driving ICU Medical Inc's Surprising 15% Stock Rally?
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
Azenta to Participate in the Jefferies Global Healthcare Conference
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Robotics Stocks
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK